Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Revenue

Aclaris Therapeutics had revenue of $31.12M in the twelve months ending March 31, 2024, with 0.95% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $2.40M, a -5.14% decrease year-over-year. In the year 2023, Aclaris Therapeutics had annual revenue of $31.25M with 5.03% growth.

• Revenue (ttm): $31.12M
• Revenue Growth: +0.95%
• P/S Ratio: 2.36
• Revenue / Employee: $361,849
• Employees: 86
• Market Cap: 73.40M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	31.25M	1.50M	5.03%
Dec 31, 2022	29.75M	22.99M	340.05%
Dec 31, 2021	6.76M	279.00K	4.30%
Dec 31, 2020	6.48M	2.26M	53.35%
Dec 31, 2019	4.23M	-1.92M	-31.28%
Dec 31, 2018	6.15M	4.47M	265.48%
Dec 31, 2017	1.68M	-	-
Dec 31, 2016	0	-	-
Dec 31, 2015	0	-	-
Dec 31, 2014	0	-	-
Dec 31, 2013	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.